Hemodialysis Fistula-Related Ischemic Neuropathy in End-Stage Renal Failure: An Electrophysiological Study A Single Study in Assiut University Hospital (Hemodialysis)
Hemodialysis Fistula-Related Ischemic Neuropathy in End-Stage Renal Failure: An Electrophysiological Study A single study in Assiut university hospital
研究概览
地位
详细说明
End-stage renal failure (ESRF) represents a major global health burden, with hemodialysis being the most common renal replacement therapy. The creation of an arteriovenous fistula (AVF) Is considered the preferred vascular access for long-term hemodialysis due to its superior patency and lower complication rates compared to grafts and catheters (1-2) Despite its advantages, AVF creation may be associated with several complications, including ischemic steal syndrome and ischemic monomelic neuropathy (IMN). Ischemic neuropathy is a rare but potentially disabling complication resulting from acute or chronic ischemia of peripheral nerves following AVF creation. Patients may present with severe pain, sensory disturbances, weakness, and functional impairment of the affected limb (3-5) Early diagnosis remains challenging because symptoms may overlap with uremic neuropathy, diabetic neuropathy, and other peripheral nerve disorders commonly encountered in ESRF patients. Electrophysiological studies, including nerve conduction studies (NCS) and electromyography (EMG), provide objective assessment of nerve dysfunction and may facilitate early diagnosis and differentiation from other neuropathic conditions Limited data are available regarding the electrophysiological characteristics of AVF-related ischemic neuropathy, particularly in ESRF populations. Therefore, a comprehensive electrophysiological evaluation may contribute to improved recognition, management, and prevention of long-term disability
Hemodialysis fistula-related ischemic neuropathy is an under-recognized complication in patients with ESRF. Delayed diagnosis may lead to irreversible neurological deficits and impaired quality of life. The electrophysiological features and associated risk factors remain insufficiently characterized in many dialysis populations
This study aims to provide a detailed electrophysiological assessment of ischemic neuropathy associated with AVF creation in ESRF patients. The findings may facilitate early diagnosis, improve clinical outcomes, and contribute to developing screening and management strategies for high-risk patients
Aim of the Work:
To evaluate electrophysiological abnormalities associated with hemodialysis fistula-related ischemic neuropathy in patients with end-stage renal failure
- Primary Objective To assess peripheral nerve function using nerve conduction studies and electromyography in ESRF patients with AVF-related ischemic neuropathy
- Secondary Objectives To compare electrophysiological findings between ESRF patients with and without ischemic neuropathy To identify clinical and vascular factors associated with the development of ischemic neuropathy To determine the severity and distribution of nerve involvement To correlate electrophysiological findings with clinical manifestations and duration of AVF use
Patients and methods:
Type of the study: Analytical Cross-Sectional Case-Control Study Study Setting: The study will be conducted at Nephrology and Hemodialysis Unit at Assuit University hospital
Study duration: august 2026 - august 2027 Study populations: Patients diagnosed with end-stage renal failure undergoing maintenance hemodialysis through an arteriovenous fistula Group I (Cases) ESRF patients with clinical evidence of AVF-related ischemic neuropathy Group II (Controls)
- ESRF patients with functioning AVFs but without clinical evidence of ischemic neuropathy
- Presence of AVF
- Clinical manifestations suggestive of ischemic neuropathy after AVF creation
- Ability to provide informed consent ESRF patients on maintenance hemodialysis via AVF. No symptoms or signs of ischemic neuropathy Inclusion Criteria Age ≥18 years Diagnosed ESRF on regular hemodialysis Exclusion Criteria Pre-existing hereditary neuropathies Cervical radiculopathy Brachial plexopathy Motor neuron disease. Recent upper limb trauma. Peripheral nerve entrapment syndromes. Severe cognitive impairment. Refusal to participate
Methodology A. Clinical Assessment
All participants will undergo:
Detailed medical history, Dialysis history
AVF characteristics:
Site of fistula Duration since creation Side of fistula Previous vascular interventions
Neurological examination:
Motor assessment Sensory assessment Deep tendon reflexes Muscle strength grading using MRC scale B. Laboratory Investigations Complete blood count (CBC) Serum creatinine Blood urea nitrogen (BUN) Electrolytes HbA1c (for diabetic patients) Serum albumin Calcium and phosphorus levels C. Vascular Assessment Duplex Doppler ultrasonography of AVF Assessment of arterial flow and steal phenomenon D. Electrophysiological Assessment
Nerve Conduction Studies (NCS):
Electromyography (EMG)
研究类型
注册 (估计的)
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
: Patients diagnosed with end-stage renal failure undergoing maintenance hemodialysis through an arteriovenous fistula Group I (Cases) ESRF patients with clinical evidence of AVF-related ischemic neuropathy Group II (Controls)
- ESRF patients with functioning AVFs but without clinical evidence of ischemic neuropathy
- Presence of AVF
- Clinical manifestations suggestive of ischemic neuropathy after AVF creation
- Ability to provide informed consent ESRF patients on maintenance hemodialysis via AVF. No symptoms or signs of ischemic neuropathy
描述
Inclusion Criteria:
- Age ≥18 years
- Diagnosed ESRF on regular hemodialysis
Exclusion Criteria:
- Pre-existing hereditary neuropathies
- Cervical radiculopathy
- Brachial plexopathy
- Motor neuron disease.
- Recent upper limb trauma.
- Peripheral nerve entrapment syndromes.
- Severe cognitive impairment.
- Refusal to participate
学习计划
研究是如何设计的?
设计细节
- 观测模型:OTHER
- 时间观点:PROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Motor Nerve Conduction Velocity
大体时间:Up to 1 year post-AVF creation
|
Assessed by Nerve Conduction Studies on the upper limb with the arteriovenous fistula . Measured in meters per second. |
Up to 1 year post-AVF creation
|
|
Arteriovenous Fistula Blood Flow Volume
大体时间:Up to 1 year post-AVF creation
|
Assessed by Duplex Doppler Ultrasound on the arteriovenous fistula. Measured in milliliters per minute. |
Up to 1 year post-AVF creation
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Sensory Nerve Conduction Velocity
大体时间:Up to 1 year post-AVF creation
|
Assessed by Nerve Conduction Studies on the upper limb with the arteriovenous fistula . Measured in meters per second |
Up to 1 year post-AVF creation
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- SCT05147818
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.